Galliprant is used to treat pain associated with mild to moderate osteoarthritis (OA) in dogs.
It specifically targets the EP4 receptor, the primary mediator of canine (OA) pain. As a result of its novel mode of action, Galliprant provides OA pain relief that is comparable to that of traditional NSAIDs, while reducing the impact on the gastrointestinal system (stomach and intestines), kidneys and liver.
Galliprant is a pork flavoured tablet. Administer once daily, on an empty stomach at least one hour before food.
Summary of Product Characteristics: